These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 27261746)
21. Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals-An in vitro and in vivo approach. Maity S; Mukhopadhyay P; Kundu PP; Chakraborti AS Carbohydr Polym; 2017 Aug; 170():124-132. PubMed ID: 28521977 [TBL] [Abstract][Full Text] [Related]
22. Trimethyl chitosan nanoparticles for ocular baicalein delivery: Preparation, optimization, in vitro evaluation, in vivo pharmacokinetic study and molecular dynamics simulation. Li J; Jin X; Yang Y; Zhang L; Liu R; Li Z Int J Biol Macromol; 2020 Aug; 156():749-761. PubMed ID: 32320806 [TBL] [Abstract][Full Text] [Related]
23. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery. Ricci F; Racaniello GF; Lopedota A; Laquintana V; Arduino I; Lopalco A; Cutrignelli A; Franco M; Sigurdsson HH; Denora N Int J Pharm; 2022 Jun; 622():121905. PubMed ID: 35697201 [TBL] [Abstract][Full Text] [Related]
25. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Krauland AH; Alonso MJ Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620 [TBL] [Abstract][Full Text] [Related]
26. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity. Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018 [TBL] [Abstract][Full Text] [Related]
27. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac. Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370 [No Abstract] [Full Text] [Related]
28. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Rukmangathen R; Yallamalli IM; Yalavarthi PR Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571 [No Abstract] [Full Text] [Related]
29. Preparation, characterization of hydrophilic and hydrophobic drug in combine loaded chitosan/cyclodextrin nanoparticles and in vitro release study. Jingou J; Shilei H; Weiqi L; Danjun W; Tengfei W; Yi X Colloids Surf B Biointerfaces; 2011 Mar; 83(1):103-7. PubMed ID: 21112190 [TBL] [Abstract][Full Text] [Related]
30. Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Ibrutinib Delivery: A Potential Nanoformulation of Novel Kinase Inhibitor. Zhao L; Tang B; Tang P; Sun Q; Suo Z; Zhang M; Gan N; Yang H; Li H J Pharm Sci; 2020 Feb; 109(2):1136-1144. PubMed ID: 31606544 [TBL] [Abstract][Full Text] [Related]
31. Cationic cyclodextrin/alginate chitosan nanoflowers as 5-fluorouracil drug delivery system. Lakkakula JR; Matshaya T; Krause RW Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):169-177. PubMed ID: 27770878 [TBL] [Abstract][Full Text] [Related]
32. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization. Ayumi NS; Sahudin S; Hussain Z; Hussain M; Samah NHA Drug Deliv Transl Res; 2019 Apr; 9(2):482-496. PubMed ID: 29569027 [TBL] [Abstract][Full Text] [Related]
33. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
34. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165 [TBL] [Abstract][Full Text] [Related]
35. Preparation, characterization and in vitro release of β-galactosidase loaded polyelectrolyte nanoparticles. Zhang H; Yu H; Mei J; Zhang Y; Deng Z Int J Biol Macromol; 2018 Aug; 115():1-9. PubMed ID: 29649531 [TBL] [Abstract][Full Text] [Related]
36. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies. Chadha R; Gupta S; Pathak N Drug Dev Ind Pharm; 2012 Dec; 38(12):1538-46. PubMed ID: 22348223 [TBL] [Abstract][Full Text] [Related]
37. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis. Saini D; Fazil M; Ali MM; Baboota S; Ali J Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of β-cyclodextrin modified chitosan-poly(acrylic acid) nanoparticles and use as drug carriers. Wang X; Chen C; Huo D; Qian H; Ding Y; Hu Y; Jiang X Carbohydr Polym; 2012 Sep; 90(1):361-9. PubMed ID: 24751053 [TBL] [Abstract][Full Text] [Related]
39. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation. Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157 [TBL] [Abstract][Full Text] [Related]
40. Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma. Li J; Tian S; Tao Q; Zhao Y; Gui R; Yang F; Zang L; Chen Y; Ping Q; Hou D Int J Nanomedicine; 2018; 13():3975-3987. PubMed ID: 30022821 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]